Intersect ENT
XENT
$28.24
Share price
0.00%
Change (1 day)
17.72%
Change (1 year)
Categories
Intersect ENT (XENT) Fails to deliver data
Key failure to deliver metrics for Intersect ENT:
- Last SEC data release: 2023-04-14
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $0.15 M
Failures to deliver for Intersect ENT (XENT) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Intersect ENT (XENT) - since 2014
Volume in USD (price x number of shares), data since 2014Intersect ENT (XENT) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2022 | $6.73 M | -92.53% |
| 2021 | $90.14 M | 4919.03% |
| 2020 | $1.79 M | 13.15% |
| 2019 | $1.58 M | -45.07% |
| 2018 | $2.88 M | -46.26% |
| 2017 | $5.37 M | 128.79% |
| 2016 | $2.35 M | -93.65% |
| 2015 | $37.03 M | 7802.54% |
| 2014 | $0.46 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Ocular Therapeutix OCUL | $0.6 M | $3.35 M | 🇺🇸 USA |
 ICON plc ICLR | $18.2 M | $56.83 M | 🇮🇪 Ireland |
 Anika Therapeutics ANIK | $0.02 M | $2.36 M | 🇺🇸 USA |
 Haemonetics HAE | $8.76 M | $11.73 M | 🇺🇸 USA |